Business / Finance

RSS

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

Alcyone Lifesciences, Inc., a leader in neural intervention systems for neurological conditions and targeted drug delivery, and DNAtrix Inc., a privately held biotechnology company and a leader in oncolytic virus therapy, have entered into an exclusive clinical collaboration. Under the agreement, DNAtrix will utilize Alcyone's MEMS Cannula (AMC) targeted delivery platform for the intratumoral delivery of DNX-2401, an oncolytic adenovirus and DNAtrix's lead product for the treatment of the most aggressive form of brain cancer, glioblastoma (GBM).

19 May 2015

OrthoSpace announces completion of financing transaction

OrthoSpace Ltd. announced today the completion of a financing transaction led by HealthpointCapital, LLC, which also includes existing investors Smith & Nephew and TriVentures.

19 May 2015

ORIG3N, LabCorp form strategic partnership

ORIG3N, Inc., a pioneer in regenerative medicine and provider of induced pluripotent stem cell (iPSC) storage, called LifeCapsule, today announced a strategic collaboration with Laboratory Corporation of America Holdings.

19 May 2015

U.K Ophthalmologists lead in treatment of wet AMD patients with Oraya therapy across europe

Oraya Therapy was introduced first in the U.K., followed by Switzerland and Germany. The therapy is intended as a one-time, non-invasive treatment that maintains vision with fewer anti-vascular endothelial growth factor (anti-VEGF) injections into the eye...

19 May 2015

University of Denver Announces Dual Law/Healthcare Degree

The University of Denver now offers a dual degree between the Sturm College of Law and University College, where students may earn a Juris Doctor and Master of Science in Healthcare Leadership...

19 May 2015

Cryoport net revenues increase 44% to $1.2 million in fourth quarter 2015

Cryoport, Inc. today announced financial results for the three and twelve-month periods ended March 31, 2015.

19 May 2015

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

BioNTech AG, a fully integrated biotechnology company developing truly personalized cancer immunotherapies, announces that it has signed an agreement with Genmab A/S to jointly research, develop and commercialize multiple bispecific antibodies for cancer immunotherapy using proprietary technologies from both companies: BioNTech's proprietary immunomodulatory antibodies and Genmab's DuoBody technology platform.

19 May 2015

Linkam and Cambridge IVF work on the development of new protocols for sperm testing

IVF is becoming increasingly important as fertility and birth rates fall in developed countries. Ensuring patients get the right treatment is important both from an emotional and financial perspective...

From Linkam Scientific Instruments 18 May 2015

Healthy Delights launches five new products in GNC stores nationwide

Healthy Delights®, the leaders in confectionary nutritional products, is proud to launch five new products in GNC stores nationwide: Probiotic Chocolate Bites, Probiotic Greek Yogurt Bites, Turmeric Curcumin Chews, Magnesium Chews, and Cranberry Chews.

18 May 2015

Lab M demonstrates quality with compliance to ISO 11133:2014

Lab M has been compliant according to ISO 11133:2014 which relates to the microbiology of food, animal feed and water – culture media preparation, production, storage and testing...

18 May 2015

Immune Pharmaceuticals announces Q1 2015 financial results; files Quarterly Report on Form 10-Q

Immune Pharmaceuticals Inc. announced financial results for the first quarter ended March 31, 2015. Immune filed its Quarterly Report on Form 10-Q for the first quarter of 2015 on Friday, May 15, 2015.

18 May 2015

Catasys' total revenues increase 118% to $433,000 in first quarter 2015

Catasys, Inc., provider of proprietary health management services to health insurers and employers, today reported its first quarter 2015 financial results for the period ended March 31, 2015.

18 May 2015

AbbVie extends expiration of exchange offer to acquire common stock of Pharmacyclics

AbbVie Inc. today announced that it has extended the expiration of its exchange offer to acquire all of the outstanding shares of common stock of Pharmacyclics, Inc. to 5 p.m., New York City time, on May 22, 2015.

18 May 2015

Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today that it has partnered with Terumo Corporation to be the exclusive distributor of the GLIDEWIRE Urologic Hydrophilic Coated Guidewire, a device cleared by the FDA for urological use.

17 May 2015

CASI Pharmaceuticals reports net loss of $1.8 million for first quarter 2015

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a commercial focus on China today reported financial results for the three months ended March 31, 2015.

15 May 2015

Complete skin grafting solution to launch at Hospitalar 2015

A complete skin grafting solution for burns and trauma surgery enabling flexibility of thin and thick skin grafts will be launched by Surtex Instruments at Hospitalar 2015.

14 May 2015

EKF highlighting its expanding range of liquid stable clinical chemistry reagents at Hospitalar 2015

EKF Diagnostics will be highlighting its expanding Stanbio central laboratory clinical chemistry range at Hospitalar, 19–22 May, Sao Paulo, Brazil.

From EKF Diagnostics 14 May 2015

Great Basin Scientific revenue up 31% in first quarter 2015

Great Basin Scientific, Inc., a molecular diagnostic testing company, today reported earnings results for the quarter ended March 31, 2015. Revenue for the quarter was $458,730, which represented a 31 percent increase in year-over-year revenues, and Loss from Operations was $3.9 million.

14 May 2015

Denali launched to discover, develop effective medicines for neurodegenerative diseases

Denali Therapeutics Inc., a new biotechnology company focused on developing effective therapies for neurodegenerative diseases, announced today that it has launched with an initial investment commitment of $217 million.

14 May 2015

ZenBio, Inc. introduces GroPro™ Cell Culture Growth Supplement formulated  to replace Bovine serum

ZenBio, Inc. industry leader in robust cell-based solutions, announced today the worldwide release of a new GroPro Cell Culture Growth Supplement...

14 May 2015

Business / Finance

DNAtrix signs agreement to utilize Alcyone's MEMS platform for direct drug delivery into glioblastoma

OrthoSpace announces completion of financing transaction

ORIG3N, LabCorp form strategic partnership

U.K Ophthalmologists lead in treatment of wet AMD patients with Oraya therapy across europe

University of Denver Announces Dual Law/Healthcare Degree

Cryoport net revenues increase 44% to $1.2 million in fourth quarter 2015

BioNTech, Genmab to jointly develop and commercialize immunomodulatory antibodies for cancer

Linkam and Cambridge IVF work on the development of new protocols for sperm testing

Healthy Delights launches five new products in GNC stores nationwide

Lab M demonstrates quality with compliance to ISO 11133:2014

Immune Pharmaceuticals announces Q1 2015 financial results; files Quarterly Report on Form 10-Q

Catasys' total revenues increase 118% to $433,000 in first quarter 2015

AbbVie extends expiration of exchange offer to acquire common stock of Pharmacyclics

Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

CASI Pharmaceuticals reports net loss of $1.8 million for first quarter 2015

Complete skin grafting solution to launch at Hospitalar 2015

EKF highlighting its expanding range of liquid stable clinical chemistry reagents at Hospitalar 2015

Great Basin Scientific revenue up 31% in first quarter 2015

Denali launched to discover, develop effective medicines for neurodegenerative diseases

ZenBio, Inc. introduces GroPro™ Cell Culture Growth Supplement formulated  to replace Bovine serum

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News